Ogura T, Nishida N, Watanabe H, Omiya T, Yamauchi T, Hosoya M, Hirata H, Kashihara N, Ota Z
Third Department of Internal Medicine, Okayama University Medical School, Japan.
Res Commun Chem Pathol Pharmacol. 1994 Feb;83(2):165-78.
To investigate the alteration of the renal atrial natriuretic peptide (ANP) and arginine vasopressin (AVP) receptors in the controlled hypertensive state of spontaneously hypertensive rat (SHR) treated with antihypertensive diuretics, 12 weeks old SHRs were administered an antihypertensive diuretic, furosemide, trichloromethiazide, or indapamide, daily for 10 days and investigated by radiolabeled receptor assay (RRA) of ANP and AVP. The urine volume was significantly increased in all groups treated with antihypertensive diuretics as compared with the untreated control group on day 3. Systolic blood pressure was significantly decreased in groups treated with both trichloromethiazide and indapamide. The number of renal ANP receptors decreased; affinity was increased only in the SHR administered indapamide. The affinity of the renal AVP receptor was also decreased in that group. Alteration of ANP and AVP receptors was observed only in the group treated with indapamide. This indicates that the ANP and AVP receptor in the kidney of SHR was changed not only by diuresis or reduction of blood pressure, but by the pharmacological action of indapamide.
为研究抗高血压利尿剂治疗自发性高血压大鼠(SHR)控制高血压状态下肾心房利钠肽(ANP)和精氨酸加压素(AVP)受体的变化,对12周龄的SHR每日给予抗高血压利尿剂呋塞米、三氯噻嗪或吲达帕胺,持续10天,然后通过ANP和AVP的放射性标记受体测定(RRA)进行研究。在第3天,与未治疗的对照组相比,所有接受抗高血压利尿剂治疗的组尿量均显著增加。三氯噻嗪和吲达帕胺治疗组的收缩压显著降低。肾ANP受体数量减少;仅在给予吲达帕胺的SHR中亲和力增加。该组肾AVP受体的亲和力也降低。仅在吲达帕胺治疗组中观察到ANP和AVP受体的变化。这表明SHR肾脏中的ANP和AVP受体不仅因利尿或血压降低而改变,还因吲达帕胺的药理作用而改变。